115 related articles for article (PubMed ID: 38113612)
1. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages.
Brugnolo A; Orso B; Girtler N; Ferraro PM; Arnaldi D; Mattioli P; Massa F; Famà F; Argenti L; Biffa G; Morganti W; Buonopane S; Uccelli A; Morbelli S; Pardini M
Cortex; 2024 Feb; 171():413-422. PubMed ID: 38113612
[TBL] [Abstract][Full Text] [Related]
2. Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.
Grober E; Lipton RB; Sperling RA; Papp KV; Johnson KA; Rentz DM; Veroff AE; Aisen PS; Ezzati A
Neurology; 2022 Mar; 98(13):e1327-e1336. PubMed ID: 35197359
[TBL] [Abstract][Full Text] [Related]
3. Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).
Bauckneht M; Chincarini A; Piva R; Arnaldi D; Girtler N; Massa F; Pardini M; Grazzini M; Efeturk H; Pagani M; Sambuceti G; Nobili F; Morbelli S
Alzheimers Res Ther; 2018 Apr; 10(1):35. PubMed ID: 29615111
[TBL] [Abstract][Full Text] [Related]
4. Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer's Disease (MCI-AD).
Brugnolo A; Girtler N; Doglione E; Orso B; Massa F; Donegani MI; Bauckneht M; Morbelli S; Arnaldi D; Nobili F; Pardini M
Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33445437
[TBL] [Abstract][Full Text] [Related]
5. Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment.
Caffarra P; Ghetti C; Ruffini L; Spallazzi M; Spotti A; Barocco F; Guzzo C; Marchi M; Gardini S
J Alzheimers Dis; 2016; 51(1):27-31. PubMed ID: 26836012
[TBL] [Abstract][Full Text] [Related]
6. Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.
Roy K; Pepin LC; Philiossaint M; Lorius N; Becker JA; Locascio JJ; Rentz DM; Sperling RA; Johnson KA; Marshall GA
J Alzheimers Dis; 2014; 42(1):291-300. PubMed ID: 24898635
[TBL] [Abstract][Full Text] [Related]
7. Unawareness of memory deficit in amnestic MCI: FDG-PET findings.
Nobili F; Mazzei D; Dessi B; Morbelli S; Brugnolo A; Barbieri P; Girtler N; Sambuceti G; Rodriguez G; Pagani M
J Alzheimers Dis; 2010; 22(3):993-1003. PubMed ID: 20858977
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.
Morbelli S; Bauckneht M; Arnaldi D; Picco A; Pardini M; Brugnolo A; Buschiazzo A; Pagani M; Girtler N; Nieri A; Chincarini A; De Carli F; Sambuceti G; Nobili F
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2073-2083. PubMed ID: 28785843
[TBL] [Abstract][Full Text] [Related]
9. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
[TBL] [Abstract][Full Text] [Related]
10. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
[TBL] [Abstract][Full Text] [Related]
11. Cognitive dysfunction in patients with very mild Alzheimer's disease and amnestic mild cognitive impairment showing hemispheric asymmetries of hypometabolism on ¹⁸F-FDG PET.
Murayama N; Ota K; Kasanuki K; Kondo D; Fujishiro H; Fukase Y; Tagaya H; Sato K; Iseki E
Int J Geriatr Psychiatry; 2016 Jan; 31(1):41-8. PubMed ID: 25820930
[TBL] [Abstract][Full Text] [Related]
12. Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints.
Brugnolo A; Morbelli S; Arnaldi D; De Carli F; Accardo J; Bossert I; Dessi B; Famà F; Ferrara M; Girtler N; Picco A; Rodriguez G; Sambuceti G; Nobili F
J Alzheimers Dis; 2014; 39(1):103-13. PubMed ID: 24150105
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
[TBL] [Abstract][Full Text] [Related]
14. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
[TBL] [Abstract][Full Text] [Related]
15. Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment.
Wabik A; Trypka E; Bladowska J; Statkiewicz M; Sąsiadek M; Zimny A
J Transl Med; 2022 Jun; 20(1):259. PubMed ID: 35672750
[TBL] [Abstract][Full Text] [Related]
16. Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.
Habeck C; Risacher S; Lee GJ; Glymour MM; Mormino E; Mukherjee S; Kim S; Nho K; DeCarli C; Saykin AJ; Crane PK;
Brain Imaging Behav; 2012 Dec; 6(4):568-83. PubMed ID: 23179062
[TBL] [Abstract][Full Text] [Related]
17. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
[TBL] [Abstract][Full Text] [Related]
18. Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
Sörensen A; Blazhenets G; Rücker G; Schiller F; Meyer PT; Frings L;
Neuroimage Clin; 2019; 21():101637. PubMed ID: 30553760
[TBL] [Abstract][Full Text] [Related]
19. Greater medial temporal hypometabolism and lower cortical amyloid burden in ApoE4-positive AD patients.
Lehmann M; Ghosh PM; Madison C; Karydas A; Coppola G; O'Neil JP; Huang Y; Miller BL; Jagust WJ; Rabinovici GD
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):266-73. PubMed ID: 23965289
[TBL] [Abstract][Full Text] [Related]
20. Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints.
Matías-Guiu JA; Cabrera-Martín MN; Valles-Salgado M; Pérez-Pérez A; Rognoni T; Moreno-Ramos T; Carreras JL; Matías-Guiu J
Am J Geriatr Psychiatry; 2017 Jul; 25(7):730-740. PubMed ID: 28238814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
